Raleigh Capital Management’s Boston Scientific BSX Stock Holding History

Raleigh Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$230K	Sell	5,395 -431	-7%	-$23.4K	0.07%	192
2026 Q1	$366K	Buy	5,826 +1,547	+36%	+$124K	0.13%	156
2025 Q4	$408K	Buy	4,279 +2,051	+92%	+$201K	0.15%	141
2025 Q3	$218K	Sell	2,228 -2,083	-48%	-$216K	0.08%	186
2025 Q2	$463K	Sell	4,311 -608	-12%	-$61.5K	0.19%	127
2025 Q1	$496K	Sell	4,919 -890	-15%	-$89.6K	0.22%	121
2024 Q4	$519K	Buy	5,809 +449	+8%	+$39.5K	0.2%	120
2024 Q3	$449K	Buy	5,360 +560	+12%	+$44.1K	0.17%	132
2024 Q2	$370K	Buy	4,800 +368	+8%	+$26.9K	0.16%	141
2024 Q1	$304K	Buy	4,432 +953	+27%	+$61.3K	0.13%	173
2023 Q4	$201K	Buy	3,479 +318	+10%	+$17K	0.09%	186
2023 Q3	$167K	Buy	3,161 +114	+4%	+$5.98K	0.09%	182
2023 Q2	$165K	Buy	3,047 +343	+13%	+$17.9K	0.08%	194
2023 Q1	$135K	Buy	+2,704	New	+$127K	0.07%	205

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Raleigh Capital Management's BSX Position: Q2 2026 in Review

Raleigh Capital Management reduced its Boston Scientific (BSX) stake by 7.4% in Q2 2026, selling an estimated $23.4K and leaving 5,395 shares worth $230K. The position accounts for 0.07% of the portfolio, ranked #192.

Raleigh Capital Management first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. The position peaked at $519K in Q4 2024. 283 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Raleigh Capital Management held 5,395 shares of Boston Scientific worth $230K as of Q2 2026.
Raleigh Capital Management sold 431 Boston Scientific shares in Q2 2026, an estimated $23.4K.
Boston Scientific made up 0.07% of Raleigh Capital Management's portfolio in Q2 2026, its #192 holding.
Raleigh Capital Management first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
Raleigh Capital Management's Boston Scientific position peaked at $519K in Q4 2024.
283 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.